Hypertension: Renal denervation-promising data from the DENERHTN trial

Wen-Yi Yang; Jan A Staessen

doi:10.1038/nrneph.2015.28

Hypertension: Renal denervation-promising data from the DENERHTN trial

Nat Rev Nephrol. 2015 May;11(5):258-60. doi: 10.1038/nrneph.2015.28. Epub 2015 Mar 10.

Authors

Wen-Yi Yang¹, Jan A Staessen¹

Affiliation

¹ Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Kapucijnenvoer 35, Box 7001, BE-3000 Leuven, Belgium.

PMID: 25752835
DOI: 10.1038/nrneph.2015.28

Abstract

In patients with resistant hypertension, renal denervation plus standardized stepped-care antihypertensive treatment (SSAHT) resulted in significant blood-pressure lowering compared with SSAHT alone. These new data from the DENERHTN trial may indicate that despite the failure of SYMPLICITY HTN-3, there is light at the end of the tunnel for renal denervation.

Publication types

Comment

MeSH terms

Antihypertensive Agents / therapeutic use*
Catheter Ablation / methods*
Denervation / methods*
Female
Humans
Hypertension / therapy*
Male

Substances

Antihypertensive Agents